Oral Session 3-11C ATL: Prognostic Factors

[OS3-11C-1] Proteomic analysis in HTLV-1 carriers and ATL patients reveals candidate biomarkers for ATL onset

Carmina Louise H. Guerrero¹, Yoshiko Yamashita², Megumi Kuba-Miyara³, Naoki Imaizumi⁴, Shugo Sakihama⁵, Masaki Hayashi⁶, Takashi Miyagi⁷, Satoko Morishima⁸, Kennosuke Karube⁵, Hiroaki Masuzaki⁸, Takuya Fukushima¹ (1.Laboratory of Hematoimmunology, Graduate School of Health Sciences, University of the Ryukyus, Nishihara City, Okinawa, Japan, 2.HealthTech Business Development Office, Corporate Business Development Division, NEC Corporation, Minato, Tokyo, Japan, 3.Okinawa University, Naha, Okinawa, Japan, 4.Laboratory of Molecular Genetics, Graduate School of Health Sciences, University of the Ryukyus, Nishihara, Okinawa, Japan, 5.Department of Pathology and Cell Biology, Graduate School of Medicine, University of the Ryukyus, Nishihara, Okinawa, Japan, 6.Department of Hematology, Nakagami Hospital, Okinawa, Okinawa, Japan, 7.Department of Hematology, Heart Life Hospital, Nakagusuku, Okinawa, Japan, 8.Division of Endocrinology, Diabetes and Metabolism, Hematology, Rheumatology (Second Department of Internal Medicine), Graduate School of Medicine, University of the Ryukyus, Nishihara, Okinawa, Japan)